Adhäsionsmoleküle auf zirkulierenden humanen Monozyten bei essentieller HypertonieSusan Katrin Lau 234Die Arbeit ist meinen Eltern in Liebe und Dankbarkeit gewidmet.1071.81.1.91.2.101.3.11121.4.389#227131.4.1.1.5.141.5.1.15161.5.2.17623#368181.5.3.19201.6.211.6.1.1.6.2.221.6.3.23241.7.251.7.1.1.7.2.262.27283.293.1.303.2.31323.3.333.3.1.537#296343.3.2.193#15635605#1263.3.3.3.3.4.3.4.36373.5.383.5.1.39557#3933.5.2.40605#2273.5.3.41303#336276#19142280#224568#1563.6.433.6.1.3.6.2.3.7.44362#34845374#319374#2893.8.46474.4.1.4.1.1.484.1.2.49324#2574.1.3.50567#3034.1.4.514.2.524.2.1.300#172623#31653453#3784.2.2.54311#173623#34455453#3404.2.3.623#36056453#340453#3404.2.4.57334#234623#2984.2.5.283#1694.2.6.58276#1534.2.7.285#154624#2714.2.8.59270#1534.2.9.4.3.604.3.1.614.3.2.624.3.2.1.4.3.2.2.63485#301475#2954.3.3.644.3.3.1.4.3.3.2.654.3.3.3.664.3.4.67596#47668562#45369623#616705.5.1.71725.2.73745.3.757677785.4.5.4.1.795.4.2.8081825.4.3.83845.5.855.6.86876.88899091 Abkürzungsverzeichnis9293 Literaturverzeichnis949596979899100101102103104105106DanksagungEidesstattliche VersicherungdeInhaltsverzeichnisHilfe Literaturverzeichnis Adgey, A.: An overview of the results of clinical trials with Glykoprotein IIb/IIIa inhibitors. Am Heart J 1998; 135(4): 43-55. Aldermann, H.M., Madhava n, S. et al.: Association of the renin-sodium profil with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104. Al-Saady, N., Leatham, E., Gupta , S.: Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure. Heart 1999, 81:134-140. Altieri, D.C., Edgington, T.S . et al.: A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (MAC-1), J of Immunology 1988, 141(8): 2656-2660. Ammon C., Meyer, S . et al.: Comparitive analysis of integrin expression on monocyte derived macophages and monocyte derived dendritic cells. Immunology 2000; 100: 364-369. Arkin, S., Naprstek, B. et al.: Expression of intercellular adhesion molecule-1 (CD54) on hematopoetic progenitors. Blood 1991; 77: 948-953. Bader, M., Peters, J. et al.: Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001; 79(2-3):76-102. Bataillard, A., Renaudin, C. et al.: Silica attenuates hypertension in Lyon hypertensive rats. J Hypertens 1995; 13: 1581-1584. Bendas, G.: Selektine als neue Zielstrukturen für die Pharmaforschung.

internet

1999, GOVI-Verlag. Buemi, M., Allegra, A., Aloisi, C.: Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-Selectin in normotensive and hypertensive patients. Hypertension 1997; 30: 845-847. CAPTURE Study: Randomised placebo-controll trial of abciximab before and during coronary intervention in refractory unstable angina. Lancet 1997; May 17; 349 (9063): 1429-1435. Carlos, T., Kovach, N. et al : Human monocyte bind to two cytocine-induced adhesive ligands on cultured human endothelial cells. Blood 1991; 77 (10): 2266-2271. Chae, C.U., Lee, R.T. et al . : Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38(3): 399-403. Cheng, J., Wung, B. et al.: Cyclic strain enhances adhesion of monocytes to endothelial cells by increasing intercellular adhesion molecule-1 expression. Hypertension 1996, 28: 386-391. Clozel, M., Kuhn, H., Hefti, F.: Endothelial dysfunktion and subendothelial monocyte macrophages in hypertension, Hypertension 1991; 18: 132-134. Coller, B.S. et al.: Potential non-Glykoprotein IIb/IIIa effects of abciximab, Am Heart J 1999; 138(1 Pt 2): 1-5. Couffinthal, T., Duplaa, C. et al.: Effect of low density lipoprotein on monocyte adhesiveness to endothelial cells in vitro. Atherosclerosis 1999; 93: 35- 45. Cronstein, B.N., Kimel, S.C. et al.: A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1992; 89(21): 9991-9995. DeBount, N., Geijtenbeek, T., Ntea, M.: Integrin mediated adhesion of mononuclear cells from patients with hypercholemia. Eur J Clin Invest 1999, 29(9): 749 -57. Dechend, R., Homuth, V., Wallukat, G.: AT1 Rezeptor agonist antibodies from preeclamptic patients cause vascular cells to express tissue factor,

Franz Volhard Clinic, Berlin,

Circulation 2000; 101: 2382-2393. DeGasparo, M., Catt, K.J. et al.: International Union of Pharmacology.XXIII . The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472. DeSouza, C., Dengel, D., Macko, R.: Elevated levels of circulating cell adhaesions molecules in uncomplicated essential hypertension. J Hypertens 1997; 10:1335-1341. Deutsche Hochdruckliga, Stellungsnahme zur aktuellen Diskussion über die medikamentöse Hochdrucktherapie. Juni 2003, Therapieempfehlungen Nov. 2002,

Homepage der Deutsche Hochdruckliga.

Dörffel, Y.: Rolle peripherer Monozyten bei Patienten mit essentieller Hypertonie. Habilitation. 2002.

HU

-

Berlin

. Dörffel, Y., Franz, St., Pruß, A., Neumann, G., Rhode, W., Burmester, G., Scholze, J.: Preactivated monocytes from hypertensive patients as a factor for atheroclerosis? Atherosclerosis 157 , 2001 : 151-160 . Dörffel, Y., Lätsch, Ch. Stuhlmüller, B., Schreiber, St., Scholze, S., Burmester, G., Scholze, J.: Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999; 34 :113-117. Dougherty, G.J., Murdoch, S., Hogg, N.: The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an imune response. Eur. J. Immunol. 1988; 18: 35-39. Faas, M., Schuiling, G., Linton , E.: Activation of peripheral leucocytes in rat pregnancy and experimental preeclampsia. Am J of Obstetrics and Gynecology 2000, 182: 351-357. Frederickson; B.J.; Turner; N.A. et al.: Effects of abciximab, ticlopidine, and combined abicimab/ticlopidine therapy on platelet and leucocyte function in patients undergoing coronary angioplasty, Circulation 2000, 101(10):1122-1137. Fritsch, P.: Dermatologie und Venerologie. Springer 1998. Fu, M.L. et al.: Autoantibodies against angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000; 18: 945-953. Fukai, T., Siegfried, M. et al.: Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 1999, 85: 23-28. Hahn A.W.A., Jonas, F., Bühler F.R., Resink, T.J.: Activation of human peripheral monocytes by angiotensin II. FEBS Lett 1994; 347: 178-180. Hamm, C. Neue Thrombozytenaggregationshemmer in der Therapie der instabilen Angina. Z Kardiol 2000; 89: 1053-1056. Haugen, T. S., Skjonsberg, O., Nakstad, B.: Modulation of adhesion molecule profiles on alveolar macrophages and blood leukocytes. Respiration 1999, Nov. 66(6): 528-37. Hentzen, E.R., Neelamegham, S. et al.:, Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule- 1Blood 2000, 95(3): 911-920. Hilme, E. , Hansson, L. et al.: Abnormal immune function in malignant hypertension. J Hypertens 1993; 11: 989-994. Homuth, V., Dechend, R. et al.: Autoantikörper gegen den Angiotensin AT1-Rezeptor sind im Tiermodel einer malignen Hypertonie am kardiovaskulären Endorganschaden beteiligt. Workshop . Thieme Verlag. ZGN 2001. Homuth, V., Wallukat, G. et al.: Charakterisierung von agonistischen Autoantikörpern gegen den AT1-Rezeptor bei Patientinnen mit Präeklampsie und HELLP-Syndrom. Speculum 2000, 18: 6-14. JNC-VII (Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure) 2003, JNC-VI 1997, Report vom Server des National Heart Lung and Blood Institute. Kalra, V.K., Ying, Y. et al. : Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultered endothelial cells. J Cell Physiol 1994; 160: 154-162. Kannel, W.B.: Epidemiology of coronary atherosclerosis: post mortem vs clinical risk factors correlations. The Framingham Study. In: Gotto AM Jr, Smith L. Atherosclerosis. Springer Verlag,

New

York

, 1980: 54-56. Keidar, S.: Angiotensin, LDL peroxidation and atherosclerosis. Life Sci 1998; 63: 1-11. Kereiakes, D.J., Runyon, J. P. et al.: IIb’s are not IIb’s, The American Journal of Cardiology 2000, 85(8 Supplement1): 23-31. Kleimann, N.S. et al.: A risk-benefit assesment of abciximab in angioplasty, Drug Saf 1999, 20(1): 43-45. Kiarash, A., Pagano, P., Tayeh, M.: Upregulated Expression of rat heart intercellular adhesion molecule-1 in angiotensin-II- but not Phenylephrine- induced hypertension. Henry Ford Hospital. Detroit. Kim, J., Berliner, J., Nadler, J.: Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun 1996 24; 226 (3): 862-868. Kim, J., Chopp, M., Chen, H.: Adhesive Glykoproteins CD11a and CD18 are upregulated in the leucocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci 1995; 128(1):45-50. Komatsu, S., Panes, J., Russell, J.: Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecule-1 expression in vivo. Hypertension 1997; 29: 683-689. Konstantopoulus, K., Neelamegham, S. et al.: Venouse levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and β 2-integrin, Circulation 1998; 98: 873-882. Kranzhöfer, R., Browatzki, M. et al.: Angiotensin II activates the proinflammatory transcription factor nuclear factor κ B in human monocytes. Biochemical and Biophysical Resarch Communications 1999, 253: 826-828. Kubitschek, J. H.: HOPE-Studie, ACE Hemmer RAMIPRIL revolutioniert die Herztherapie. Bericht vom Kongreß der AHA.

Internet

2000. Landmann, R., Scherer, F. et al.: LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14. J Leukoc Biol 1995; 57: 440-449. Lang, R., Karow, Th.: Allgemeine und spezielle Pharmakologie und Toxikologie.

Bergisch-

Gladbach

. 2000. Langstein, J., Becke, F.M., Sollner, L. et al.: Comparative analysis of CD137 and LPS effects on monocyte activation, survival and proliferation. Biochem Biophys Res Commun 2000; 273:117-122. Lenter, M., Uhlig, H., Hamann, A.: A monoclonal antibody against activation epitope on mouse integrin chain β 1 blocks adhesion of lymphocytes to the edothelial integrin α 6 β 1. Cell Biology 1993; 90: 9051-55. Leung, P.S., Tsai, S.J., Wallukat, G. et al.: The upregulation of angiotensin II receptor AT(1) in human preeclamtic placenta. Mol Cell Endocrinol 2001; 184(1-2):95-102. Ley, K.: Molecular mechanisms of leukocyte recruitement in the inflamatory process. Cardiovasc Res 1996; 32(4):733-742. Ley, K.: Selektine und Integrine bei Ischämie und Arteriosklerose. Vortrag Deutsches Rheumaforschungszentrum.

Berlin

2001. Lilly : Firmeninformation

:

http://www.reopro.com/US/science/

Linz, W. : Long-term angiotensin II type 1 receptor blockade doubles lifespan of hypertensive rats. Hypertension 2000; 35: 908. Liu, Y., Liu, T., McCarron R., Spatz, M.: Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol 1996 Jun, 270: H2125-2131. Lo, S., Cheung, A., Zheng, Q.: Induction of tissue factor on monocytes by adhesion to endothelial cells. J of Immunology 1995, 154: 4768-4777. Lopes-Virella, M. et al.: Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunology 1985; 37: 377-386. Lüschner, T., Noll, G. et al.: The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995; 118:81-90 Luft, F.C.: Angiotensin, inflammation, hypertension, and cardivascular disease. Curr Hypertens Rep 2001; 3(1): 61-67. Luft, F.C .: Hypertension as a complexe genetic trait . Semin Nephrol 2002; 22(2):115-126. Lundahl, J., Skold, C. et al.: Monocyte and neutrophil adhesion to matrix proteins is selectivly enhanced in the presence of inflammatory mediators. Scand J Immunol 1996 Aug ; 44(2): 143-149. Luscinskas, F. et al.: Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-Selektin, β 1 Integrins and β 2 integrins. J of cell biology 94; 125: 1417-1427. Luther, H., Homuth, V., Wallukat, G. et al.: Alpha-1–adrenergic receptor antibodies in patients with primary hypertension. Hypertension. 1997, 29(2): 678-82. Macey, M., McCarthy, D. et al. : Effects of cell purification methods on CD11b and L-Selektin expression as well as the adherence and activation of leucocytes . J Immunol Methods 1995; 181(2):211-219. Masuda, M., Takahashi,H. et al.: Adhesion of leukocytes to endothelial cells in artherosclerosis. Rinsho Byori 1998 Nov, 46(11): 1149-1155. McCarron, R., Wang, L., Siren, A.: Monocyte adhesion to cerebrovascular endothelial cells derived from hypertensive and normotensive rat. Am J Physiol 1994; 267: H2491-H2497. Meniconi, A. et al.: Ist die Arteriosklerose eine Infektionskrankheit? Praxis 1998; 87: 64-74. Meisel, S., Shapiro H., Radnay, J.: Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and MAC-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction. J Am Coll Cardiol 1998; 31(1):120-125. Mervaala, E.M., Muller, D. et al.: Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.

Franz Volhard Clinic

. Hypertension 1999, 33, 1Pt 2: 389-395. Mervaala, E.M., Muller, D., Dechend, R. et al.: Cycolsporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes. Hypertension 2000; 35: 360-366. Mickelson, J.K., Ali, M.N. et al.: Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutophils from patients undergoing coronary angioplasty, JACC 1999; 33(1): 97-106. Mills, P., Farag, N. et al.: Peripheral blood mononuklear cell CD62L and CD11a expression and soluble interstitial cell adhesion molecule-1 levels following infused isoproterenol in hypertension. J Hypertension 2002; 20 (2): 311-316. Muller, D., Dechend, R. et al.: Angiotensin-induced inflammation and novel approaches to treatment. Adv Nephrol Necker Hosp 2001; 31: 89-103. Muller D., Heissmeyer, V. et al.: Aspirin inhibits NF- κ B and protects from angiotensin II-induced organ damage . Faseb Journal 2001, 15 (10):1822-1828 Muller, D.N., Mervaala, E.M., Luft, F.C. et al.: Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol. 2002 Nov; 161(5):1679-1693. Muller, W.A., Randolph, G.J. et al.: Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes.J Leukoc Biol 1999 Nov; 66(5): 698-704. Review. Nagata, K. et al.: Effects of blockade of the renin – agingiotensin system on tissue factor and plasminogen activator-1 synthesis in human cultured monocytes. J Hypertens 2001; 19: 776-789. Nakashima, Y. et al.: Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites. Arterioslerosis, Thrombosis and vascular biology. 1998; 18: 842-851. Neumann, F.J., Zohlnhofer D. et al.: Effect of Glykoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin MAC-1 in acute myocardial infarction , J Am Coll Cardiol 1999; 34 (5):1420-1426. Nickening, G. , Böhm, M. et al.: Bedeutung des Angiotensin-II-Rezeptors AT1 für die Ent-stehung von arterieller Hypertonie und Arteriosklerose. Dtsch. med. Wschr. 1997; 122: 1009-1013. Plescia, J., Conte, M.S. et al.: Molecular identification of the cross-reacting epitope on α M β 2 Integrin I Domain recognized bei the Anti- α IIb β 3 monoclonal antibody 7E3 and its involvement in leucocyte adherence. J of Biological Chemistry 1998, 273(32): 20372-20377. Potter, D. D., Sobey C.G. et al.: Evidence that macrophages in atherosclerotic lesions contain Angiotensin II. Circulation 1998; 98: 800-807. Randolph, G.J. , Luther, T., Muller, et al.: Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998; 92(11): 4167-4177. Roitt, I, Brostoff, J., Male, D.: Immunology. Mosby-Verlag.

London

1998. Ross, R.: The pathogenesis of atherosclerosis: a perspectiv for the 1990s. Nature. 1993; 362: 801-809. Ross, R.: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 38: 71-79 Rubio, M., Sotillos, M., Jochems, G. et al.: Monocyte activation: rapid induction of α 1/ β (VLA4) integrin expression by LPS and interferon. Eur J Immunol. 1995; 25 :2701-2705. Scannell, G., Waxmann, K. et al.: Hypoxia-induced alteration of neutrophil membrane receptors. J Surg Res 1995; 59: 141-145. Schmitz, G., Herr, Rothe et al.: T-Lymphozyten und Monozyten in der Pathogenese der Arteriosklerose. Herz 1998; 23: 168–177. Scholze, J.: Hypertonie. Risikokonstellationen und Begleiterkrankungen. Blackwell Wissenschaftsverlag.

Berlin

,

Wien

1999. Shen, Y., Rattan, V.: Cigarette smoke condensate-induced adhesion molecule expression and transmigration of monocytes. Am J Physiol 1996; 270: H1624-1633. Simon, B., Noll, Maisch et al.: Endotheliale Dysfunktion - eine Bestandsaufnahme und Ansätze zur Therapie. Herz 1999; 24: 62 – 71. Simon, D.I., Xu, H. et al. : 7 E3 monoclonal antibody directed against the platelet Glykoprotein IIb/IIIa cross-reacts with the leucocyte integrin MAC-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol 1997; 17(3): 528-535. Spiering, W, Kroon, A. et al.: Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000, 36: 411-416. Stent, G., Crowe, S.M. et al.: Effects of monocyte purification and culture on integrin expression. APMIS 1997; 105: 663-670. Stohlawetz, P., Hahn, P., Koller, M.: Immunophenotypic characterisatics of monocytes in elderly subjects. Scand J Immunol 1998; 48(3): 324-326. Strawn, W., Gallagher, P., Talant, E.: Angiotensin II AT 1–Rezeptor blockade inhibits monocyte activation and adherence in transgenetic (mRen2)27 rats. J of Cardiovascular pharmacology 1999; 33: 341-351. Suzuki, K., Masawa, N. et al.: The pathogenesis of cerebrovascular lessions in hypertensive rats. Med Elektron Microsc 2001; 34(4): 230-239. Theuer, J., Dechend, R. et al.: Angiotensin II induced inflammation in the kidney and the heart of double transgenic rats. BMC Cardiovascular Disorders 2002, 2:3. Tsao, Ph. et al.: Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioslerosis, Thrombosis and vascular biology 1998; 18: 947-953. Tummala, P., Chen, X., Sundell, C.: Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculatur. Circulation 1999; 100: 1223-1229. Violi, F. et al.: Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease . Results from the A.D.E.P. study. Atherosclerosis 1996; 120: 25-35. Vogel, R.A.: Coronary risk factors, endothelial function and atherosclerosis. Clin. Cardiol. 1997; 20: 426-432. Wallukat, G., Homuth, V., Fischer, TH. et al.: Patients with preeclampsia develop agonist autoantibodies against the angiotensin AT1 Rezeptor, J Clin Invest 1999; 103: 945-952. Wambach, G., Fritschka, E.: Arterielle Hypertonie und vaskuläres System. Upjohn GmbH. 1994 WHO/ISH: Guidelines for Management of Hypertension. J of Hypertension 1999; 17(1): 151-183. Wick, G. et al.: Is arteriosclerosis an immunologically mediated disease? Immunol Today 1995; 16(1): 27-33. Xiong, H. et al.: The expression of CD11a and CD11b on leucocytes in cerebral thrombosis, Hua Xi Yi Ke Da Xue Xue Bao. 1998 Dec; 29(4): 415-417. Yusuf, S., Sleight P. et al.: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; Jan 20, 342(3): 145-153.